Age comorbidity scores as risk factors for 90‐day mortality in patients with a pancreatic head adenocarcinoma receiving a pancreaticoduodenectomy: A National Population‐Based Study-Reference-Cited by-同舟云学术

Age comorbidity scores as risk factors for 90‐day mortality in patients with a pancreatic head adenocarcinoma receiving a pancreaticoduodenectomy: A National Population‐Based Study

Published:2019-12-02 Issue:2 Volume:9 Page:562-574
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Shia Ben‐Chang¹²³,Qin Lei⁴,Lin Kuan‐Chou⁵⁶,Fang Chih‐Yuan⁵⁶,Tsai Lo‐Lin⁵⁶,Kao Yi‐Wei⁷,Wu Szu‐Yuan⁸⁹¹⁰¹¹¹²^ORCID

Affiliation:

1. Research Center of Big Data College of management Taipei Medical University Taipei Taiwan

2. College of Management Taipei Medical University Taipei Taiwan

3. Executive Master Program of Business Administration in Biotechnology College of Management Taipei Medical University Taipei Taiwan

4. School of Statistics University of International Business and Economics Beijing China

5. Division of Oral and Maxillofacial Surgery Department of Dentistry Wan Fang Hospital Taipei Medical University Taipei Taiwan

6. School of Dentistry College of Oral Medicine Taipei Medical University Taipei Taiwan

7. Graduate Institute of Business Administration Fu Jen Catholic University Taipei Taiwan

8. Department of Food Nutrition and Health Biotechnology College of Medical and Health Science Asia University Taichung Taiwan

9. Division of Radiation Oncology Lo‐Hsu Medical Foundation Lotung Poh‐Ai Hospital Yilan Taiwan

10. Big Data Center Lo‐Hsu Medical Foundation Lotung Poh‐Ai Hospital Yilan Taiwan

11. Department of Healthcare Administration College of Medical and Health Science Asia University Taichung Taiwan

12. Department of Radiology School of Medicine College of Medicine Taipei Medical University Taipei Taiwan

Funder

Taipei Medical University

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2730

Reference76 articles.

1. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma

2. Cancer statistics, 2017

3. National Health Insurance Administration Ministry of Health and Welfare Taiwan R.O.C. (2014). National Health Insurance Annual Report 2014‐2015 2016.

4. Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy

5. Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) study;HPB;2024-08

2. Comorbidity assessment methods and their significance in predicting the results of treatment of older patients undergoing elective abdominal surgeries for cancer – A scoping review;Cancer Epidemiology;2024-08

3. Updates in the Surgical Management of Pancreatic Ductal Adenocarcinoma;Gastroenterology Clinics of North America;2024-08

4. Adverse postoperative outcomes in elderly patients with sarcopenia;BMC Geriatrics;2024-06-27

5. An Age-Stratified Analysis of Early Postoperative Mortality Among Medicare-Eligible Patients With Common Gastrointestinal and Hepato-pancreato-biliary Malignancies;The American Surgeon™;2024-06-05